DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer

被引：0
|
作者：
Chiman Mohammadi
Rezvan Najafi
机构：
[1] Hamadan University of Medical Sciences,Research Center for Molecular Medicine
来源：
Journal of Gastrointestinal Cancer | 2020年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：714 / 715
页数：1
相关论文
共 50 条
  • [41] DCLK1 autoinhibition and activation in tumorigenesis
    Cheng, Linna
    Yang, Zejing
    Guo, Wenhao
    Wu, Chengyong
    Liang, Shufang
    Tong, Aiping
    Cao, Zhongwei
    Thorne, Rick F.
    Yang, Sheng-Yong
    Yu, Yamei
    Chen, Qiang
    INNOVATION, 2022, 3 (01):
  • [42] Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments
    Wu, Xiangyan
    Qu, Dongfeng
    Weygant, Nathaniel
    Peng, Jun
    Houchen, Courtney W.
    CANCERS, 2020, 12 (02)
  • [43] DCLK1 Labels Adult Pancreatic Progenitor and Cancer Initiating Cells
    Westphalen, Christoph B.
    Chen, Xiaowei
    Renz, Bernhard W.
    Worthley, Daniel L.
    Asfaha, Samuel
    Houchen, Courtney W.
    May, Randal
    Remotti, Helen
    Quante, Michael
    Olive, Kenneth P.
    Wang, Timothy C.
    GASTROENTEROLOGY, 2013, 144 (05) : S142 - S142
  • [44] Dclk1 labels quiescent pancreatic progenitor and cancer initiating cells
    Westphalen, Christoph Benedikt
    Quante, Michael
    Worthley, Daniel
    Asfaha, Samuel
    Remotti, Helen
    Olive, Kenneth P.
    Wang, Timothy C.
    CANCER RESEARCH, 2012, 72
  • [45] Identification of MSX1 and DCLK1 as mRNA Biomarkers for Colorectal Cancer Detection Through DNA Methylation Information
    Sun, Ai-Jun
    Gao, Hai-Bo
    Liu, Gao
    Ge, Heng-Fa
    Ke, Zun-Ping
    Li, Sen
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (07) : 1879 - 1884
  • [46] Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer
    Kalantari, Elham
    Ghods, Roya
    Zanjani, Leili Saeednejad
    Rahimi, Mandana
    Eini, Leila
    Razmi, Mahdieh
    Asadi-Lari, Mohsen
    Madjd, Zahra
    CANCER BIOMARKERS, 2022, 33 (03) : 277 - 289
  • [47] Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway
    YE Qiaobei
    ZHU Yu
    SHI Meng
    LV Linxi
    GONG Yuyan
    ZHANG Luyao
    YANG Lehe
    ZHAO Haiyang
    ZHAO Chengguang
    XU Huanhai
    Chinese Journal of Natural Medicines, 2024, 22 (04) : 318 - 328
  • [48] Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway
    Ye, Qiaobei
    Zhu, Yu
    Shi, Meng
    Lv, Linxi
    Gong, Yuyan
    Zhang, Luyao
    Yang, Lehe
    Zhao, Haiyang
    Zhao, Chengguang
    Xu, Huanhai
    CHINESE JOURNAL OF NATURAL MEDICINES, 2024, 22 (04) : 318 - 328
  • [49] DCLK1 might be a therapeutic target of osthole against cervical cancer
    Pan, Liuliu
    Zhang, Xiaodan
    Wang, Danhan
    Huang, M. I. N.
    Huang, Qiusui
    Duan, Ping
    Mei, Jie
    PHARMAZIE, 2021, 76 (10): : 503 - 506
  • [50] Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis
    Elham Kalantari
    Mahdieh Razmi
    Fatemeh Tajik
    Mohsen Asadi-Lari
    Roya Ghods
    Zahra Madjd
    Cancer Cell International, 22
12345